Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Clinical trial NCT01192295 · COMPLETED
Trial details
- NCT number
- NCT01192295
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-07-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.